Clinical Trials on ARID1A Gene Mutation in United Kingdom
Total 0 results
Nothing found
Sponsors and Collaborators
- Laboratoires Iprad-Vegebom
- Health Holding Company, Hail Health Cluster, Saudi Arabia
- NATURAmedicatrix Sàrl
- Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
- Zhijun Sun
- Epicentre, Paris, France.
- Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
- Resurge Therapeutics Inc.
- Kettering Foundation
- Paul W. Read, MD
- Carlos III Health Institute
- Remedy Institute
- Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
- Prader-Willi Syndrome Association of Australia
- Sociedad Española de Arteriosclerosis
- The Depressive and Bipolar Disorder Alternative Treatment Foundation
- Australian Childhood Foundation
- Sonogenix
- Brigham and Womens' Hospital, Center for Surgery and Public Health
- wenbinlu
- View Full List
Medical Conditions
- Marginal Zone B-cell Lymphoma
- Pregnancy; Accident
- Psychoactive Substance Use
- Lymphoblastic Lymphoma
- Stage III Childhood Anaplastic Large Cell Lymphoma
- Adherence to In-Office Glaucoma Evaluation Appointment
- Mycobacterium Avium Complex Infections
- Escape Room Games and Role Playing Gamification
- Cell Senescence
- Ankle Trauma
- Neurobehavioral Manifestation
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Hernia,Ventral
- Apneic; Oxygenation
- Refractory B-Lineage Lymphoma
- Stage IIIB Esophageal Adenocarcinoma
- Spinocerebellar Ataxia Genotype Type 3
- Intervention Studies
- Malignant Tumor of Extrahepatic Bile Duct
- Stroke Recrudescence
- View Full List
Drug Interventions
- Gadoteridol (ProHance)
- Everolimus
- Colecalciferol D3 (Vigantol Oil)
- LINjeta U-100 Insulin
- Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
- ART-123
- Irinotecan
- Optiva artificial tear by Allergan
- Low molecular weight Heparin as standard of care treatment
- Oral Aztreonam
- FRSW107
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- Fenofibric acid 135mg
- Fostamatinib
- Omeprazole 40 mg
- Epalrestat
- SBI-087
- Lansoprazole 15mg QD
- 300 mg of caffeine citrate infusion
- Triple therapy
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Denmark
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Ireland
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Morocco
- Contract Research Organizations in Oman
- Contract Research Organizations in Romania
- Contract Research Organizations in Serbia
- Contract Research Organizations in Türkiye
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in United States
- CRO list by country